Dr. Cassie Kline-Nunnally, the first-ever recipient of a Cannonball Kids’ cancer (CKc) Young Investigator grant, is receiving a new $100,000 grant from CKc to begin a clinical trial which measures the efficacy of a new oral drug on brain tumors including diffuse intrinsic pontine glioma (DIPG), MYC-driven medulloblastoma, and high-grade glioma (HGG). The outcome for these specific pediatric brain cancers are very poor. This new study, developed and led by Dr. Kline-Nunnally at UCSF Benioff Children’s Hospital, creates options for up to 30 children and will be accessible at 18 children’s hospitals across the United States, Washington D.C. and Canada. The grant, awarded during Childhood Cancer Awareness Month, is named for Grayson Jack, a two-year-old boy from Winter Garden, FL, who was diagnosed with an Astrocytoma Grade 4 brain tumor after he turned two. Grayson is currently undergoing treatment at Arnold Palmer Hospital for Children in Orlando, FL.
Donations go directly towards funding pediatric cancer research projects to make better treatments for kids battling cancer so they may not endure the horrific pain or develop secondary cancers associated with their treatment.
CANNONBALL KIDS' CANCER FOUNDATION,
POST OFFICE BOX 547797
ORLANDO, FL 32854
CANNONBALL KIDS' CANCER FOUNDATION IS A 501(c)(3) NON-PROFIT COMMUNITY SERVICE ORGANIZATION. CANNONBALL KIDS' CANCER FOUNDATION'S REGISTRATION NUMBER IS CH41586. A COPY OF THE OFFICIAL REGISTRATION AND FINANCIAL INFORMATION MAY BE OBTAINED FROM THE DIVISION OF CONSUMER SERVICES BY CALLING TOLL-FREE, 1-800-435-7352 WITHIN THE STATE OF FLORIDA OR BY VISITING www.800helpfla.com. REGISTRATION DOES NOT IMPLY ENDORSEMENT, APPROVAL, OR RECOMMENDATION BY THE STATE.